Log In
person
Biogen Inc
BIIB
summarize
3 total product lines
calendar_month
Revenue as of 12/31/2023
| Reporting Segmentarrow_drop_up | Product Line | Amount (USD) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (USD) | Percentage |
| Biopharmaceuticals |
Branded Pharmaceuticals
These companies research, develop, and manufacture patented drugs.
|
7.25B | 73.68% |
| Biopharmaceuticals |
Pharmaceutical Patent Licensing
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
1.69B | 17.18% |
| Biopharmaceuticals |
Pharmaceutical Contract Developer and Manufacturing Organizations (CDMOs)
These companies, commonly known as CDMOs, provide specialized services for drug manufacturers, such as drug discovery, research, development, and manufacturing.
|
0.9B | 9.14% |
| keyboard_arrow_down |
Biopharmaceuticals
Branded Pharmaceuticals
|
7.25B | 73.68% |
| keyboard_arrow_right |
These companies research, develop, and manufacture patented drugs.
|
||
| keyboard_arrow_down |
Biopharmaceuticals
Pharmaceutical Patent Licensing
|
1.69B | 17.18% |
| keyboard_arrow_right |
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
||
| keyboard_arrow_down |
Biopharmaceuticals
Pharmaceutical Contract Developer and Manufacturing Organizations (CDMOs)
|
0.9B | 9.14% |
| keyboard_arrow_right |
These companies, commonly known as CDMOs, provide specialized services for drug manufacturers, such as drug discovery, research, development, and manufacturing.
|
||